Michi Yukawa Elected President-Elect of California Hawaii Regional SGIM

Michi Yukawa, MD has assumed the prestigious role of President-Elect for the California Hawaii Regional Society of General Internal Medicine (SGIM) this year. In this capacity, Dr. Yukawa will collaborate closely with the planning committee to orchestrate the upcoming regional SGIM meeting, scheduled to take place at UC Law San Francisco on Saturday, January 27, 2024.

Dr. Yukawa extends a warm invitation to all interested parties, encouraging their active participation and the submission of their work for poster or oral presentation. Furthermore, the organizing committee is open to workshop proposals, providing an excellent opportunity for meaningful engagement within the SGIM community.

HIV-1, HTLV-1 and normal T-cell growth: transcriptional strategies and surprises.

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine.

Predicting the individualized risk of poor adherence to ART medication among adolescents living with HIV in Uganda: the Suubi+Adherence study.

Targeting the erythrocytic and liver stages of malaria parasites with s-triazine-based hybrids.

Clinical decisions. Mammography screening for breast cancer.

Infectious granulomatous dermatitis associated with Rothia mucilaginosa bacteremia: A case report.

Single photon radioluminescence. I. Theory and spectroscopic properties.

The emerging fungal pathogen Candida auris induces IFNγ to colonize mammalian hair follicles.

Suicide Genes Breathe New Life into Cell Therapies.

Randomized Clinical Trial Representativeness and Outcomes in Real-World Patients: Comparison of 6 Hallmark Randomized Clinical Trials of Relapsed/Refractory Multiple Myeloma.

Dr. Nynikka Palmer elected to serve on the Board of Directors for the Academy of Communication in Healthcare

Congrats to Dr. Nynikka Palmer!

Nynikka Palmer, DrPH, MPH was elected to serve on the Board of Directors for the Academy of Communication in Healthcare, the premier research education and advocacy organization whose mission is to improve communication in contemporary healthcare.

Nynikka will serve as Expert in Communication Research to Promote Health Equity.

Find out more about the Academy of Communication in Health Care 

Here

Nynikka Palmer, DrPH, MPH is an Assistant Professor at the University of California San Francisco (UCSF), in the Division of General Internal Medicine at Zuckerberg San Francisco General Hospital, with secondary appointments in the Departments of Urology and Radiation Oncology. Her research program focuses on unraveling multilevel mechanisms of cancer disparities – particularly inequities in quality of care among African American men with prostate cancer, cultural influence, patient-centered communication, and strategies to enhance delivery of high-quality cancer care. She currently has a National Cancer Institute K01 career development award to bridge the divide between low-income African American men and equal prostate cancer treatment by anchoring the evidence-based intervention of peer navigation in the relational concept of African American brotherhood as a means to foster trust and empowerment, and optimize patient-centered communication and quality of care. She is also quantitatively examining the communication patterns between newly diagnosed African American prostate cancer patients and their providers in the context of treatment decision-making and patient-centered communication, using the Roter Interaction Analysis System. Additionally, she has established a support group for African American men facing prostate cancer to promote survivorship and empowerment, which has been thriving since September 2014. She is also co-leader of the Prostate Cancer Task Force of the San Francisco Cancer Initiative (SF CAN) – a city-wide initiative to eliminate prostate cancer disparities through community outreach and education, targeted early detection and appropriate follow-up of aggressive disease, navigation and support services, and institutional partnerships that ensure high-quality care across healthcare institutions.        

Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.

Population Pharmacokinetics of Piperaquine in Young Ugandan Children Treated With Dihydroartemisinin-Piperaquine for Uncomplicated Malaria.

Comparison of outcomes for patients with nonischemic cardiomyopathy taking intravenous inotropes versus those weaned from or never taking inotropes at cardiac resynchronization therapy.